covid banner

Covid-19 resources: Department for Business, Energy and Industrial strategy

Click here to return to the Covid-19 index page.

Page updated 3 June 2021.

  • Press release – Over £100 million cash boost to manufacture millions of doses of COVID-19 vaccine

New state-of-the-art centre to scale up COVID-19 vaccine and gene therapy manufacturing gets £100 million investment.

  • Press release – UK government secures new Covid-19 vaccines and backs global clinical trial

UK citizens will receive early access to 90 million doses of 2 COVID-19 vaccine candidates should they prove safe and effective.

  • Press release – Public encouraged to register for COVID-19 vaccine trials as 100,000 already sign-up

Over 100,000 people have volunteered to take part in COVID-19 vaccine trials, helping to speed up efforts to discover a safe and effective vaccine.

  • Press release – 10,000 UK volunteers to take part in new COVID-19 vaccine trials

Ten thousand UK volunteers will be invited to join a leading phase 3 COVID-19 vaccine trial.

  • Press release – Ethnic minority communities and the elderly called upon to bolster the fight against coronavirus

Researchers are calling on more people from Black, Asian and minority ethnic backgrounds and the over 65s to volunteer for clinical studies through the NHS Vaccine Registry.

  • Press release – Expert partnership to explore and establish Human Challenge studies of COVID-19 in the UK

£33.6 million government investment will back the studies in partnership with Imperial College London, hVIVO and the Royal Free London NHS Foundation Trust.

  • Press release – Expert partnership to explore and establish Human Challenge studies of COVID-19 in the UK

£33.6 million government investment will back the studies in partnership with Imperial College London, hVIVO and the Royal Free London NHS Foundation Trust.

  • Government response – UK government response to Pfizer/BioNTech’s publication of efficacy data of their COVID-19 vaccine

Pfizer/BioNTech published positive efficacy results from Phase 3 studies of their potential COVID-19 vaccine.

  • Press release – Janssen to begin COVID-19 vaccine trials in the UK

Pharmaceutical company to begin trials of UK vaccine from 16 November.

Biotech company Moderna has published positive efficacy results from its Phase 3 studies of its potential COVID-19 vaccine.

Vaccine could be delivered to the UK from Spring 2021.

The government, through the work of the Vaccine Taskforce, has put the UK in an extremely strong position if and when a vaccine meets robust standards of safety and effectiveness

  • Report – Government has published a report highlighting the work and achievements of its Vaccines Taskforce (VTF).

 

  • Press release  – Novavax publishes positive efficacy data for its COVID-19 vaccine

Novavax today published positive data from the UK phase 3 study of its COVID-19 vaccine candidate, showing it to be 89.3% effective in preventing coronavirus in participants.

  • Press release – Janssen publishes positive safety and efficacy data for single-dose COVID-19 vaccine

Janssen today published positive data from the Phase 3 studies of its single-dose COVID-19 vaccine candidate, showing it to be 66% effective overall in preventing coronavirus in participants.

  • Press release – UK government secures additional 40 million doses of Valneva vaccine

Deal takes total number of Valneva vaccines to 100 million, to be manufactured in the UK in Scotland

  • Press release – World’s first coronavirus Human Challenge study receives ethics approval in the UK

The UK will be the first country in the world to run a Covid-19 human challenge study, following approval from the UK’s clinical trials ethics body

  • Correspondence – Coronavirus (COVID-19): Letter to businesses on workplace testing, February 2021

Letter from the Secretary of State for Business, Energy and Industrial Strategy to all businesses registered in England about free COVID-19 tests for staff who cannot work from home.

  • Press release – Update on the Vaccine Taskforce: 1 March 2021

Responsibility for the Vaccine Taskforce is to move jointly to the Department of Health and Social Care (DHSC) and the Department for Business, Energy and Industrial Strategy (BEIS).

Notice to display to show you have made your workplace COVID-secure.